All changes for the tissue musculoskeletal system (343)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA498
ataxin 1
Molecular
skeletal muscle
Human
ATXN1
3.0% Increase Gene Expression Level
DAA509
BCL2-associated athanogene 2
Molecular
skeletal muscle
Human
BAG2
3.0% Decrease Gene Expression Level
DAA354
BCS1-like (yeast)
Molecular
skeletal muscle
Human
BCS1L
3.0% Decrease Gene Expression Level
DAA568
bone morphogenetic protein receptor, type IB
Molecular
skeletal muscle
Human
BMPR1B
11.0% Decrease Gene Expression Level
DAA477
bolA homolog 3 (E. coli)
Molecular
skeletal muscle
Human
BOLA3
5.0% Decrease Gene Expression Level
DAA541
brain protein 44-like
Molecular
skeletal muscle
Human
BRP44L
5.0% Decrease Gene Expression Level
DAA453
butyrophilin-like 3
Molecular
skeletal muscle
Human
BTNL3
5.0% Decrease Gene Expression Level
DAA478
chromosome 11 open reading frame 73
Molecular
skeletal muscle
Human
C11orf73
3.0% Decrease Gene Expression Level
DAA309
chromosome 14 open reading frame 2
Molecular
skeletal muscle
Human
C14orf2
2.0% Decrease Gene Expression Level
DAA504
chromosome 16 open reading frame 61
Molecular
skeletal muscle
Human
C16orf61
4.0% Decrease Gene Expression Level
DAA342
chromosome 18 open reading frame 19
Molecular
skeletal muscle
Human
C18orf19
5.0% Decrease Gene Expression Level
DAA520
complement component 1, r subcomponent
Molecular
skeletal muscle
Human
C1R
8.0% Increase Gene Expression Level
DAA367
complement component 1, s subcomponent
Molecular
skeletal muscle
Human
C1S
7.0% Increase Gene Expression Level
DAA385
chromosome 2 open reading frame 88
Molecular
skeletal muscle
Human
C2orf88
4.0% Decrease Gene Expression Level
DAA487
complement component 3
Molecular
skeletal muscle
Human
C3
16.0% Increase Gene Expression Level
DAA480
chromosome 4 open reading frame 17
Molecular
skeletal muscle
Human
C4orf17
13.0% Decrease Gene Expression Level
DAA358
chromosome 6 open reading frame 136
Molecular
skeletal muscle
Human
C6orf136
3.0% Decrease Gene Expression Level
DAA404
chromosome 7 open reading frame 44
Molecular
skeletal muscle
Human
C7orf44
4.0% Decrease Gene Expression Level
DAA506
chromosome 9 open reading frame 123
Molecular
skeletal muscle
Human
C9orf123
2.0% Decrease Gene Expression Level
DAA443
carbonic anhydrase IV
Molecular
skeletal muscle
Human
CA4
6.0% Decrease Gene Expression Level
DAA364
chromobox homolog 7
Molecular
skeletal muscle
Human
CBX7
4.0% Increase Gene Expression Level
DAA507
coiled-coil domain containing 72
Molecular
skeletal muscle
Human
CCDC72
2.0% Increase Gene Expression Level
DAA469
CD207 molecule, langerin
Molecular
skeletal muscle
Human
CD207
7.0% Decrease Gene Expression Level
DAA408
CDC42 effector protein (Rho GTPase binding) 3
Molecular
skeletal muscle
Human
CDC42EP3
6.0% Increase Gene Expression Level
DAA419
cadherin 5, type 2 (vascular endothelium)
Molecular
skeletal muscle
Human
CDH5
6.0% Decrease Gene Expression Level
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA498 | ataxin 1 | Molecular | skeletal muscle | Human | ATXN1 | 3.0% Increase Gene Expression Level | |
DAA509 | BCL2-associated athanogene 2 | Molecular | skeletal muscle | Human | BAG2 | 3.0% Decrease Gene Expression Level | |
DAA354 | BCS1-like (yeast) | Molecular | skeletal muscle | Human | BCS1L | 3.0% Decrease Gene Expression Level | |
DAA568 | bone morphogenetic protein receptor, type IB | Molecular | skeletal muscle | Human | BMPR1B | 11.0% Decrease Gene Expression Level | |
DAA477 | bolA homolog 3 (E. coli) | Molecular | skeletal muscle | Human | BOLA3 | 5.0% Decrease Gene Expression Level | |
DAA541 | brain protein 44-like | Molecular | skeletal muscle | Human | BRP44L | 5.0% Decrease Gene Expression Level | |
DAA453 | butyrophilin-like 3 | Molecular | skeletal muscle | Human | BTNL3 | 5.0% Decrease Gene Expression Level | |
DAA478 | chromosome 11 open reading frame 73 | Molecular | skeletal muscle | Human | C11orf73 | 3.0% Decrease Gene Expression Level | |
DAA309 | chromosome 14 open reading frame 2 | Molecular | skeletal muscle | Human | C14orf2 | 2.0% Decrease Gene Expression Level | |
DAA504 | chromosome 16 open reading frame 61 | Molecular | skeletal muscle | Human | C16orf61 | 4.0% Decrease Gene Expression Level | |
DAA342 | chromosome 18 open reading frame 19 | Molecular | skeletal muscle | Human | C18orf19 | 5.0% Decrease Gene Expression Level | |
DAA520 | complement component 1, r subcomponent | Molecular | skeletal muscle | Human | C1R | 8.0% Increase Gene Expression Level | |
DAA367 | complement component 1, s subcomponent | Molecular | skeletal muscle | Human | C1S | 7.0% Increase Gene Expression Level | |
DAA385 | chromosome 2 open reading frame 88 | Molecular | skeletal muscle | Human | C2orf88 | 4.0% Decrease Gene Expression Level | |
DAA487 | complement component 3 | Molecular | skeletal muscle | Human | C3 | 16.0% Increase Gene Expression Level | |
DAA480 | chromosome 4 open reading frame 17 | Molecular | skeletal muscle | Human | C4orf17 | 13.0% Decrease Gene Expression Level | |
DAA358 | chromosome 6 open reading frame 136 | Molecular | skeletal muscle | Human | C6orf136 | 3.0% Decrease Gene Expression Level | |
DAA404 | chromosome 7 open reading frame 44 | Molecular | skeletal muscle | Human | C7orf44 | 4.0% Decrease Gene Expression Level | |
DAA506 | chromosome 9 open reading frame 123 | Molecular | skeletal muscle | Human | C9orf123 | 2.0% Decrease Gene Expression Level | |
DAA443 | carbonic anhydrase IV | Molecular | skeletal muscle | Human | CA4 | 6.0% Decrease Gene Expression Level | |
DAA364 | chromobox homolog 7 | Molecular | skeletal muscle | Human | CBX7 | 4.0% Increase Gene Expression Level | |
DAA507 | coiled-coil domain containing 72 | Molecular | skeletal muscle | Human | CCDC72 | 2.0% Increase Gene Expression Level | |
DAA469 | CD207 molecule, langerin | Molecular | skeletal muscle | Human | CD207 | 7.0% Decrease Gene Expression Level | |
DAA408 | CDC42 effector protein (Rho GTPase binding) 3 | Molecular | skeletal muscle | Human | CDC42EP3 | 6.0% Increase Gene Expression Level | |
DAA419 | cadherin 5, type 2 (vascular endothelium) | Molecular | skeletal muscle | Human | CDH5 | 6.0% Decrease Gene Expression Level |